Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming H Zheng

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|July 30, 2021
Investigating lymphangiogenesis in vitro and in vivo using engineered human lymphatic vessel networksShira Landau, Abigail Newman, Shlomit Edri, et al.
Journal of Orthopaedic Translation|June 7, 2021
Reduction of mechanical loading in tendons induces heterotopic ossification and activation of the β-catenin signaling pathwayTao Wang, Peilin Chen, Lianzhi Chen, et al.
Journal of Cellular Physiology|May 5, 2007
Calcium/calmodulin-dependent kinase activity is required for efficient induction of osteoclast differentiation and bone resorption by receptor activator of nuclear factor kappa B ligand (RANKL)Estabelle S M Ang, Ping Zhang, James H Steer, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 13, 2015
Alexidine Dihydrochloride Attenuates Osteoclast Formation and Bone Resorption and Protects Against LPS-Induced OsteolysisXiang Zhu, Junjie Gao, Pei Y Ng, et al.
Biochemical Pharmacology|February 25, 2016
Thonzonium bromide inhibits RANKL-induced osteoclast formation and bone resorption in vitro and prevents LPS-induced bone loss in vivoXiang Zhu, Jun J Gao, Euphemie Landao-Bassonga, et al.
Journal of Cellular Biochemistry|October 29, 2011
Paclitaxel inhibits osteoclast formation and bone resorption via influencing mitotic cell cycle arrest and RANKL-induced activation of NF-κB and ERKEstabelle S M Ang, Nathan J Pavlos, Shek Man Chim, et al.
Tissue Engineering. Part B, Reviews|October 18, 2012
Bioreactor design for tendon/ligament engineeringTao Wang, Bruce S Gardiner, Zhen Lin, et al.
Molecular and Cellular Biology|June 1, 2005
Rab3D regulates a novel vesicular trafficking pathway that is required for osteoclastic bone resorptionNathan J Pavlos, Jiake Xu, Dietmar Riedel, et al.
The Journal of Biological Chemistry|March 27, 2009
Myocyte enhancer factor 2 and microphthalmia-associated transcription factor cooperate with NFATc1 to transactivate the V-ATPase d2 promoter during RANKL-induced osteoclastogenesisHaoTian Feng, Taksum Cheng, James H Steer, et al.
Journal of Cellular Physiology|August 15, 2009
Caffeic acid phenethyl ester, an active component of honeybee propolis attenuates osteoclastogenesis and bone resorption via the suppression of RANKL-induced NF-kappaB and NFAT activityEstabelle S M Ang, Nathan J Pavlos, Lee Y Chai, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Proceedings of the National Academy of Sciences of the United States of America|July 30, 2021
Investigating lymphangiogenesis in vitro and in vivo using engineered human lymphatic vessel networksShira Landau, Abigail Newman, Shlomit Edri, et al.
Journal of Orthopaedic Translation|June 7, 2021
Reduction of mechanical loading in tendons induces heterotopic ossification and activation of the β-catenin signaling pathwayTao Wang, Peilin Chen, Lianzhi Chen, et al.
Journal of Cellular Physiology|May 5, 2007
Calcium/calmodulin-dependent kinase activity is required for efficient induction of osteoclast differentiation and bone resorption by receptor activator of nuclear factor kappa B ligand (RANKL)Estabelle S M Ang, Ping Zhang, James H Steer, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 13, 2015
Alexidine Dihydrochloride Attenuates Osteoclast Formation and Bone Resorption and Protects Against LPS-Induced OsteolysisXiang Zhu, Junjie Gao, Pei Y Ng, et al.
Biochemical Pharmacology|February 25, 2016
Thonzonium bromide inhibits RANKL-induced osteoclast formation and bone resorption in vitro and prevents LPS-induced bone loss in vivoXiang Zhu, Jun J Gao, Euphemie Landao-Bassonga, et al.
Journal of Cellular Biochemistry|October 29, 2011
Paclitaxel inhibits osteoclast formation and bone resorption via influencing mitotic cell cycle arrest and RANKL-induced activation of NF-κB and ERKEstabelle S M Ang, Nathan J Pavlos, Shek Man Chim, et al.
Tissue Engineering. Part B, Reviews|October 18, 2012
Bioreactor design for tendon/ligament engineeringTao Wang, Bruce S Gardiner, Zhen Lin, et al.
Molecular and Cellular Biology|June 1, 2005
Rab3D regulates a novel vesicular trafficking pathway that is required for osteoclastic bone resorptionNathan J Pavlos, Jiake Xu, Dietmar Riedel, et al.
The Journal of Biological Chemistry|March 27, 2009
Myocyte enhancer factor 2 and microphthalmia-associated transcription factor cooperate with NFATc1 to transactivate the V-ATPase d2 promoter during RANKL-induced osteoclastogenesisHaoTian Feng, Taksum Cheng, James H Steer, et al.
Journal of Cellular Physiology|August 15, 2009
Caffeic acid phenethyl ester, an active component of honeybee propolis attenuates osteoclastogenesis and bone resorption via the suppression of RANKL-induced NF-kappaB and NFAT activityEstabelle S M Ang, Nathan J Pavlos, Lee Y Chai, et al.
Pageof 7